1.
Voinescu CD, Mozere M, Genovese G, et al. A Neanderthal haplotype introgressed into the human genome confers protection against membranous nephropathy. Kidney international. 2024. doi:10.1016/j.kint.2024.01.017.
1.
Wulczyn KE, Shafi T, Anderson A, et al. Metabolites Associated With Uremic Symptoms in Patients With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2024. doi:10.1053/j.ajkd.2023.11.013.
1.
Hughes O, Bentley AR, Breeze CE, et al. Genome-wide study investigating effector genes and polygenic prediction for kidney function in persons with ancestry from Africa and the Americas. Cell genomics. 2023;4(1):100468. doi:10.1016/j.xgen.2023.100468.
1.
Sewerin S, Aurnhammer C, Skubic C, et al. Mechanisms of pathogenicity and the quest for genetic modifiers of kidney disease in branchiootorenal syndrome. Clinical kidney journal. 2024;17(1):sfad260. doi:10.1093/ckj/sfad260.
1.
Reiner AP, Raffield LM, Franceschini N, et al. Effect of Sickle Cell Trait and Genotype on the Association of Soluble uPAR with Kidney Function Measures in Black Americans. Clinical journal of the American Society of Nephrology : CJASN. 2021;16(2):287-289. doi:10.2215/CJN.12100720.
1.
Zhou W, Simic P, Zhou IY, et al. Kidney glycolysis serves as a mammalian phosphate sensor that maintains phosphate homeostasis. The Journal of clinical investigation. 2023;133(8). doi:10.1172/JCI164610.